Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2003
12/04/2003WO2003087356A3 Helicokinin-receptor from insects
12/04/2003WO2003086457A3 Method of treating or preventing autoimmune disease
12/04/2003WO2003086456A3 Anti-ck18 monoclonal antibody and therapeutic and diagnostic uses thereof in cancer
12/04/2003WO2003083041A3 Cripto-specific antibodies
12/04/2003WO2003072736A3 Reagents and treatment methods for autoimmune diseases
12/04/2003WO2003072727A3 EGFRvIII SPECIFIC MONOCLONAL ANTIBODY AND EGFRvIII RIBOZYMES AND USE TO DETECT, TREAT OR PREVENT EGFRvIII ASSOCIATED CANCER
12/04/2003WO2003072062A3 Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders
12/04/2003WO2003070981A3 Seequences specifically deleted mycobacterium tuberculosis genome and their use in diagnostics and as vaccines
12/04/2003WO2003068201A3 High affinity antibody having a tcr-like specificity and use in detection and treatment
12/04/2003WO2003063899A3 Vaccine adjuvant based on a cd4 0 ligand
12/04/2003WO2003063768A3 Compositions and methods directed to anthrax toxin
12/04/2003WO2003061578A3 Compositions for treatment or prevention of bioterrorism
12/04/2003WO2003059290A3 Diagnostic and therapeutic uses of topors
12/04/2003WO2003057168A3 Cancer-associated epitope
12/04/2003WO2003054158A3 Rapidly maturing fluorescent proteins and methods for using the same
12/04/2003WO2003054017A3 Mono-and dual chemokine/cytokine constructs
12/04/2003WO2003053465A3 Lyophilized preparation containing antibodies to the egf receptor
12/04/2003WO2003051290A3 Treating b-cell mediated diseases by modulating dr6 activity
12/04/2003WO2003048328A3 Antibodies against carboxic anhydrase ix (ca ix) tumor antigen
12/04/2003WO2003040725A3 Method of determining whether a patient afflicted with cancer can be treated by a therapeutic agent that targets the 17-1a antigen
12/04/2003WO2003035892A9 Novel methods for introducing molecules into cells and vectors and compositions for use in such methods
12/04/2003WO2003031462A3 Nogo receptor-mediated blockade of axonal growth
12/04/2003WO2003028537A3 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer
12/04/2003WO2003025002A3 Method and compositions of defensin-antigen fusion proteins and chemokine-antigen fusion proteins as vaccines for tumors and viral infection
12/04/2003WO2003022879A3 Peptides mimicking a cryptic epitope of gp41 hiv-1 and antibodies directed against them
12/04/2003WO2003021273A3 Diagnosis of carcinomas
12/04/2003WO2003018798A3 G-protein coupled receptor and dna sequences thereof
12/04/2003WO2003016491A3 Retrovirus isolated from mantle histiocytes in mantle cell lymphoma
12/04/2003WO2003008579A3 Polynucleotides expressed in dendritic cells and polypeptides encoded thereby
12/04/2003WO2003007803A3 Methods for diagnosing and treating alzheimer's disease and parkinson's disease
12/04/2003WO2003006996A3 Natural ligand of gpcr chemr23 and uses thereof
12/04/2003WO2002102310A3 Proteins associated with cell growth, differentiation, and death
12/04/2003WO2002102303A3 Crystals and structure of synagis fab
12/04/2003WO2002086090A3 Identification of essential genes of aspegillus fumigatus and methods of use
12/04/2003WO2002082077A3 Production of polyclonal monospecific antibodies against upar variants del4, del5 and del4+5, and the use thereof for diagnostic and therapeutical purposes
12/04/2003WO2002074986A3 An early pre-symptomatic prion diagnostic blood test for encephalopathies
12/04/2003WO2002070708A3 Glutamate receptor modulatory proteins and nucleic acids encoding them
12/04/2003WO2002064827A3 Nucleic acids of the human abca12 gene, vectors containing such nucleic acids, and uses thereof
12/04/2003WO2002064742A3 Compounds effecting neuron remodeling and assays for same
12/04/2003WO2002057427A3 Mammalian tumor susceptibility gene products and their uses
12/04/2003WO2002030462A3 Hedgehog antagonists, methods and uses related thereto
12/04/2003US20030226155 Modified transferrin-antibody fusion proteins
12/04/2003US20030225254 Comprises monoclonal antibody for treating and prevention of tumor progression; antitumor agents
12/04/2003US20030225253 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/04/2003US20030225251 Specificity exchangers that redirect antibodies to a pathogen
12/04/2003US20030225250 Intestinal trefoil proteins
12/04/2003US20030225021 Methods of inducing the expression of bone morphogenetic proteins (BMPs) and transforming growth factor-beta proteins (TGF-betas) in cells
12/04/2003US20030224984 Treating trauma such as wounds, various cancers, and disorders of the vessels including atherosclerosis and cardiac hypertrophy.
12/04/2003US20030224982 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/04/2003US20030224979 Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
12/04/2003US20030224972 Inhibiting melanin production by melanocytes.
12/04/2003US20030224490 Fusion partner cells and uses thereof
12/04/2003US20030224487 Novel cytokine zcytor17 ligand
12/04/2003US20030224478 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/04/2003US20030224458 Novel human G-protein coupled receptor, HGPRBMY23, expressed highly in kidney
12/04/2003US20030224453 Structural models for cytoplasmic domains of transmembrane receptors
12/04/2003US20030224452 Preparing immunoglobulin for use as tool in immunoassay for determining pregnancy in ruminants; animal husbandry; in vito fertilization; veterinary medicine
12/04/2003US20030224451 Novel protein related to melanoma-inhibiting protein and uses thereof
12/04/2003US20030224447 For preparation of immunogens, antibodies and conjugates, for use in competitive immunoassays for the detection of ketamine ((+-)-2-(o-chlorophenyl)-2-(methylamino)cyclohexanone) and its primary metabolite, norketamine
12/04/2003US20030224444 Antibodies to native conformations of membrane proteins
12/04/2003US20030224443 Novel epithelial tissue imaging agent
12/04/2003US20030224433 Bovine germline D-genes and their application
12/04/2003US20030224413 Comprises polynucleotides coding restriction fragment length polymorphism for use in identifying, characterizing and treatment of blood, respiratory, tumor and nervous system disorders
12/04/2003US20030224408 Ligand screening and discovery
12/04/2003US20030224403 Treating anthrax infection comprising administering/exposing cells to inhibitor of lethal toxin (LETX) and antibiotic and monitoring/evaluating toxin activity in cells
12/04/2003US20030224402 Progression suppressed gene 13 (PSGen 13) and uses thereof
12/04/2003US20030224400 Novel human G-protein coupled receptor, HGPRBMY11, and variants thereof
12/04/2003US20030224397 Preparing immunoglobulins comprised of alterations in hypervariable region for use as tools in human diagnostics and therapeutics
12/04/2003US20030224386 Compositions, kits, and methods for identification, assessment, prevention, and therapy of rheumatoid arthritis
12/04/2003US20030224376 Novel human transferase family members and uses thereof
12/04/2003US20030224358 Comprises nucleotide sequences coding membrane protein for use as anticarcinogenic/antitumor/antiinflammatory agent
12/04/2003US20030224352 Comprises lymphadenopathy viral sequences for diagnosis of aquired immuno-depressive syndromes
12/04/2003US20030224016 Transport peptides such as C-terminal Erns peptide and analogues thereof
12/04/2003US20030224012 Identifying a BASB033 polypeptide or an antibody that is immunospecific for such polypeptide, present with in a biological sample form the animal suspected having meningococcus induced infections and meningitis
12/04/2003US20030224011 A polypeptide or protein complex carrier and one or more HCV (Hepatitis C virus) mimotopes to provide antigens able to generate antibodies for recognizing the hypervariable region of HCV E2 protein
12/04/2003US20030224007 A protective protein in the form of vaccine, containing a polypeptide from a pro-region of a cathepsin L protease obtained from excretory/secretory products of newly excysted juvenile stages of Fasciola hepatical
12/04/2003US20030224005 Applying a formulation containing interferon gamma antibodies topically to the eye to treat hyperimmune reactions, such as transplant rejection, autoimmune diseases of the eye and ocular disorders connected with autoimmune diseases
12/04/2003US20030224001 Administering to a cancer patient an effective amount of a molecule having the constant region of a human antibody and the hypervariable region of monoclonal antibody 225 to treat the cancer
12/04/2003US20030224000 Methods for blocking or alleviating staphylococcal nasal colonization by intranasal application of monoclonal antibodies
12/04/2003US20030223999 Use of trifunctional bispecific and trispecific antibodies for the treatment of malignant ascites
12/04/2003US20030223998 Use of gamma delta + T cells to identify and respond to a specific antigen expressed by acute lymphoblstic leukemia (ALL)
12/04/2003US20030223997 Nucleic acid and corresponding protein entitled 121P1F1 useful in treatment and detection of cancer
12/04/2003US20030223996 Analyzing the level of B lymphocte stimulator (BLyS) expression in a sample of an individual using antibodies, comparing the level of BLyS assayed in biological sample with a standard level of BLyS expresion in normal sample
12/04/2003US20030223995 Treatment of pemphigus vulgaris
12/04/2003US20030223994 Protein ligands comprising an immunoglobulin heavy chain variable (VH) domain and an immunoglobulin light chain variable (VL) domain, wherein the proteins bind a complex comprising an MHC and a peptide, do not substantially bind the
12/04/2003US20030223992 G-protein coupled receptor ligands and methods
12/04/2003US20030223991 Modulating activity of the immune system using agonists or antagonists of a CD200 receptor. Also provided are methods of treatment and diagnosis of immune disorders.
12/04/2003US20030223990 A novel gene (designated 193P1E1B) and its encoded protein, and variants thereof, are described wherein 193P1E1B exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers. 193P1E1 provides
12/04/2003US20030223989 CD137 agonists to treat patients with IgE-mediated conditions
12/04/2003US20030223988 Reducing the occurrence of fever, headache, nausea and/or vomiting associated with administration of a therapeutic compound to a mammal in need thereof, comprising administering to the mammal a first conditioning dose of a nontarget cell
12/04/2003US20030223986 Methods
12/04/2003US20030223985 Globulin protein to lower cholesterol in humans
12/04/2003US20030223973 Discloses the protease stratum corneum chymotrytic enzyme (SCCE) is specifically over-expressed in ovarian and other malignancies. A number of SCCE peptides can induce immune responses to SCCE, thereby demonstrating the potential of
12/04/2003CA2704273A1 Mn/ca ix-antibody binding specifically to non-immunodominant epitope of mn/ca ix and uses thereof
12/04/2003CA2487557A1 Modulators and inhibitors of fibroblast growth factor receptor 5 polypeptides and gene expression thereof
12/04/2003CA2486621A1 Induction and maintenance of tolerance to composite tissue allografts
12/04/2003CA2486620A1 Chimeric allograft tolerance induction, monitoring and maintenance
12/04/2003CA2486619A1 Methods and materials for treating inflammatory conditions
12/04/2003CA2486578A1 Detection of secreted polypeptides
12/04/2003CA2485733A1 Vaccines
1 ... 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 ... 1494